Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection
Background: Heart transplantation remains the gold standard for end-stage heart failure, with current ex vivo organ storage times limited to 4 to 6 h before critical tissue damage occurs. Many preservation solutions exist in an attempt to limit both ischemic and reperfusion damage. In order to compa...
| Main Authors: | , , , , , |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
BIOMED CENTRAL LTD
2017
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10150/622950 http://arizona.openrepository.com/arizona/handle/10150/622950 |